A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)

Clinical trial NCT01124786 · COMPLETED

Trial details

NCT number: NCT01124786
Sponsor: Clovis Oncology, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma

Start date: 2010-05-01
Primary completion: 2012-11-01
Enrollment: 367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.